Delgocitinib, also known as Anzupgo, has been given the green light for NHS use for adults with moderate to severe chronic ...

A study has found that people with eczema are able to bathe either daily or weekly, without any impact on their symptoms.

The recommendation for delgocitinib, also known as Anzupgo and made by Leo Pharma, could also save the NHS millions of pounds ...

The cream can be used at home and is applied twice a day to the affected areas on the hands and wrists - it should be offered ...

TENS of thousands of people in England suffering from debilitating eczema could soon be free of agonising symptoms after a ...

The National Institute for Health and Care Excellence (Nice) has recommended that the cream should be offered to people with ...

According to Nice, the rollout of delgocitinib could reduce outpatient procedures such as phototherapy, as well as freeing up ...

New research shows people with allergies—like asthma, eczema, or hay fever—may face higher post-surgery risks, slower healing, and increased infections.

Chronic hand eczema is now considered a “common” skin disease in the United States, according to results from the CHECK study ...

Children whose eczema developed earlier, lasted longer and was more severe were less likely to outgrow their food allergy, ...

In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader who found milk of magnesia to be an effective deodorant alternative.

A new treatment for those suffering from "chronic" eczema is set to be available on the NHS within the next three months.